Minovia Therapeutics

Mitochondrial Augmentation Cell-therapy Platform

Active Public Startup Founded 2011-12

Minovia Therapeutics treats mitochondrial diseases through cell therapy using its Mitochondrial Augmentation Therapy (MAT) platform. The companys initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments. The company developed a cell therapy approach to treat a broad range of indications generated by a mitochondrial…

SectorHealth Tech & Life Sciences
StagePublic
Total raised$28.4M
Employees26
Founded2011-12
HQ
Patents1
Confidence100
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients